Patents-Review.com
ClassID:

97143 ⎘

C07K16/1278 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)

Recent Application in this class:
#1
20260102478
2026-04-16

Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions

 #2
20250042978
2025-02-06

VHH BASED BINDING ANTIBODIES FOR ANTHRAX AND BOTULINUM TOXINS AND METHODS OF MAKING AND USING THEREFOR

 #3
20240349732
2024-10-24

AFFINITY MOLECULES AND METHODS FOR THEIR USE

 #4
20240344102
2024-10-17

METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES

 #5
20240041049
2024-02-08

Affinity molecules and methods for their use

 #6
20230340556
2023-10-26

Methods and means for the production of Ig-like molecules

 #7
20230265172
2023-08-24

HUMANIZED ANTIBODY SPECIFIC TO BACILLUS ANTHRACIS PROTECTIVE ANTIGEN AND PREPARATION METHOD THEREOF

 #8
20230036135
2023-02-02

BCG CAR CONSTRUCTS AND METHODS OF THEIR MANUFACTURE AND USE

 #9
20210293807
2021-09-23

Compositions and methods for detection of wild type cry protein and a hybrid cry protein

 #10
20210253676
2021-08-19

Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity

 #11
20210221874
2021-07-22

VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor

 #12
20210071222
2021-03-11

Methods and means for the production of Ig-like molecules

 #13
20200255501
2020-08-13

Compounds to inhibit bacterial s-layer protein assembly

 #14
20200199206
2020-06-25

BACTERIAL TOXIN-NEUTRALIZING NANOBODIES AND METHODS OF MAKING AND USING THE SAME

 #15
20200055907
2020-02-20

Toxin Genes and Methods for Their Use

 #16
20200017897
2020-01-16

Methods and means for the production of ig-like molecules

 #17
20190247497
2019-08-15

Anti-PD-L1-anti-TIM-3 bispecific antibodies

 #18
20190225675
2019-07-25

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

 #19
20190211069
2019-07-11

Nucleic acids for single-domain antibodies with thermal stability under cytoplasmic expression

 #20
20190211068
2019-07-11

Single-domain antibody fusion proteins with the acid tail of alpha-synuclein

 #21
20190202897
2019-07-04

Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity

 #22
20190144527
2019-05-16

Monoclonal Antibodies that Neutralize Anthrax Protective Antigen (PA) Toxin

 #23
20180313833
2018-11-01

Compositions and methods for protein detection

 #24
20180292391
2018-10-11

GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS

 #25
20180289803
2018-10-11

Anti-PD-L1-anti-TIM-3 bispecific antibodies

 #26
20180259520
2018-09-13

Rapid dual direct fluorescent antibody assay for the identification of

#27
20180111981
2018-04-26

Monoclonal antibodies that neutralize anthrax toxins

 #28
20170369923
2017-12-28

Methods and means for the production of Ig-like molecules

 #29
20170362310
2017-12-21

VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor

 #30
20170333544
2017-11-23

Multivalent stable vaccine composition and methods of making same

 #31
20170327860
2017-11-16

Methods and means for the production of Ig-like molecules

 #32
20170088633
2017-03-30

Human-derived insecticidal gene and insecticidal peptide encoded thereby and application thereof

 #33
20170067880
2017-03-09

Gram-positive bacteria specific binding compounds

 #34
20170035055
2017-02-09

Human-derived insect-resistant gene and anti-CRY1B toxin idiotype single-chain antibody encoded thereby and application thereof

 #35
20170007682
2017-01-12

Multivalent stable vaccine composition and methods of making same

 #36
20170003287
2017-01-05

Rapid dual direct fluorescent antibody assay for the identification of

#37
20160376348
2016-12-29

Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity

 #38
20160368972
2016-12-22

Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein

 #39
20160347830
2016-12-01

Immunoglobulin against the anthrax toxin

 #40
20160339111
2016-11-24

Peptide core-based multi-arm linkers for treating infectious diseases

 #41
20160272698
2016-09-22

Regulating Bacillus anthracis lethal factor activity via an activating epitope region

 #42
20160235045
2016-08-18

Human artificial chromosome vector

 #43
20160222096
2016-08-04

Gram-positive bacteria specific binding compounds

 #44
20160215066
2016-07-28

Anthropogenic insect-resistant gene and Cry1C toxin idiotype single-chain antibody encoded thereby and application thereof

 #45
20160200803
2016-07-14

Monoclonal antibodies that neutralize anthrax toxins

 #46
20160193317
2016-07-07

PROTECTIVE ANTIGEN COMPLEXES WITH INCREASED STABILITY AND USES THEREOF

 #47
20160177364
2016-06-23

Methods and means for the production of Ig-like molecules

 #48
20160168232
2016-06-16

GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS

 #49
20160145324
2016-05-26

Antibodies directed to protective antigen

 #50
20160137723
2016-05-19

Monoclonal antibodies that react with the capsule of

#51
20160053278
2016-02-25

AXMI221z, AXMI222z, AXMI223z, AXMI224z, and AXMI225z delta-endotoxin genes and methods for their use

 #52
20160031971
2016-02-04

Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure

 #53
20160002321
2016-01-07

Monoclonal antibodies to anthrax protective antigen

 #54
20150376266
2015-12-31

Gram-positive bacteria specific binding compounds

 #55
20150309027
2015-10-29

Monoclonal antibodies specific for Cry1Ca and related detection methods

 #56
20150299274
2015-10-22

AXMI-115, AXMI-113, AXMI-005, AXMI-163 and AXMI-184: insecticidal proteins and methods for their use

 #57
20150265691
2015-09-24

Anthrose-based compositions and related methods

 #58
20150203548
2015-07-23

Single-domain antibodies with improved thermal stability under cytoplasmic expression

 #59
20150197766
2015-07-16

METHODS AND COMPOSITIONS FOR PRODUCTION OF RECOMBINANT PHARMACEUTICAL PROTEINS IN MEDICINAL PLANTS

 #60
20140294826
2014-10-02

Methods and compositions with a recombinant neutralizing binding protein for treating toxin exposure

 #61
20140235828
2014-08-21

Gram-positive bacteria specific binding compounds

 #62
20140227257
2014-08-14

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

 #63
20140196175
2014-07-10

AXMI221z, AXMI222z, AXMI223z, AXMI224z and AXMI225z delta-endotoxin genes and methods for their use

 #64
20140141508
2014-05-22

Recombinant carrier molecule for expression, delivery and purification of target polypeptides

 #65
20140140999
2014-05-22

Methods and means for the production of IG-like molecules

 #66
20140099314
2014-04-10

polypeptide and antibodies

 #67
20140072579
2014-03-13

Methods and means for the production of Ig-like molecules

 #68
20140056908
2014-02-27

CLOSTEROVIRUS-BASED NUCLEIC ACID MOLECULES AND USES THEREOF

 #69
20130336981
2013-12-19

Methods and means for the production of Ig-like molecules

 #70
20130310543
2013-11-21

TOXIN GENES AND METHODS FOR THEIR USE

 #71
20130305412
2013-11-14

Toxin genes and methods for their use

 #72
20130303393
2013-11-14

Immunoglobulin libraries

 #73
20130287787
2013-10-31

Monoclonal antibodies that react with the capsule of

#74
20130261293
2013-10-03

Gram-positive bacteria specific binding compounds

 #75
20130260402
2013-10-03

Anthrax carbohydrates, synthesis and uses thereof

 #76
20130253175
2013-09-26

Gram-positive bacteria specific binding compounds

 #77
20130230584
2013-09-05

Treating bladder tumor cells using fibronectin attachment protein as a target

 #78
20130104259
2013-04-25

AXMI-115, AXMI-113, AXMI-005, AXMI-163 AND AXMI-184: INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE

 #79
20130017201
2013-01-17

BISPECIFIC MONOCLONAL ANTIBODY CAPABLE OF CROSS REACTING WITH LETHAL FACTOR (LF) AND EDEMA FACTOR (EF), AND NEUTRALIZING EDEMA TOXIN (ET) AS WELL AS LETHAL TOXIN (LT) OF BACILLUS ANTHRACIS

 #80
20120282701
2012-11-08

DNA promoters and anthrax vaccines

 #81
20120282288
2012-11-08

Recombinant carrier molecule for expression, delivery and purification of target polypeptides

 #82
20120233715
2012-09-13

HUMAN ARTIFICIAL CHROMOSOME VECTOR

 #83
20120222140
2012-08-30

Human artificial chromosome vector

 #84
20120189640
2012-07-26

Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity

 #85
20120171214
2012-07-05

polypeptides and antibodies

 #86
20120171196
2012-07-05

Monoclonal antibodies that neutralize anthrax toxins

 #87
20120157665
2012-06-21

Gram-positive bacteria specific binding compounds

 #88
20120156196
2012-06-21

Methods of preventing or treating anthrax using anti-anthrax antibodies

 #89
20120149095
2012-06-14

DNA promoters and anthrax vaccines

 #90
20120114662
2012-05-10

Human monoclonal antibodies against protective antigen

 #91
20120108466
2012-05-03

Immunoglobulin libraries

 #92
20120107343
2012-05-03

Production of recombinant proteins in ciliates and uses thereof

 #93
20120015379
2012-01-19

Diagnosis of infection based on detection of bacterial secreted biomarkers

 #94
20110262477
2011-10-27

Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins

 #95
20110223163
2011-09-15

Monoclonal antibodies that react with the capsule of

#96
20110203015
2011-08-18

AXMI223z delta-endotoxin gene and methods for use

 #97
20110201033
2011-08-18

G immunoglobulin used against anthrax toxins

 #98
20110200614
2011-08-18

ANTHRAX SPECIFIC ANTIBODIES

 #99
20110171223
2011-07-14

Anti-peptide antibodies that cross react with protective antigen of and uses thereof

 #100
20110129460
2011-06-02

Combination Antibodies For The Treatment And Prevention Of Disease Caused By Bacillus Anthracis And Related Bacteria And Their Toxins

 #101
20110117104
2011-05-19

Monoclonal antibody specific to anthrax toxin

 #102
20110110954
2011-05-12

Anthrax compositions and methods of use and production

 #103
20110091465
2011-04-21

polypeptides and antibodies

 #104
20110059098
2011-03-10

Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof

 #105
20110039729
2011-02-17

Glycosylated protein expression in prokaryotes

 #106
20110033450
2011-02-10

Antibody against anthrax toxins

 #107
20110020323
2011-01-27

GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS

 #108
20100239595
2010-09-23

Equine antibodies against for passive immunization and treatment

 #109
20100239594
2010-09-23

Compositions and methods for production of immunoglobulins

 #110
20100233174
2010-09-16

Anthrax carbohydrates, synthesis and uses thereof

 #111
20100227373
2010-09-09

Recombinant carrier molecule for expression, delivery and purification of target polypeptides

 #112
20100196524
2010-08-05

Peptides and methods for producing them

 #113
20100172926
2010-07-08

Anthrax compositions and methods of use and production

 #114
20100150965
2010-06-17

DNA promoters and anthrax vaccines

 #115
20100119520
2010-05-13

Monoclonal antibodies that neutralize anthrax toxins

 #116
20100111868
2010-05-06

Monoclonal antibodies for neutralizing anthrax toxin

 #117
20100074892
2010-03-25

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

 #118
20100024077
2010-01-28

CE44-69D INSECTICIDAL COTTON

 #119
20100005543
2010-01-07

Toxin genes and methods for their use

 #120
20100004176
2010-01-07

AXMI-115, AXMI-113, AXMI-005, AXMI-163 and AXMI-184: insecticidal proteins and methods for their use

 #121
20100003263
2010-01-07

Monoclonal antibodies to anthrax protective antigen

 #122
20090324723
2009-12-31

Method of prophylaxis of infection

 #123
20090246200
2009-10-01

Anthrax carbohydrates, synthesis and uses thereof

 #124
20090215092
2009-08-27

Antibodies for Anthrax

 #125
20090202553
2009-08-13

Antibodies against anthrax protective antigen

 #126
20090123921
2009-05-14

Immunoglobulin libraries

 #127
20090110700
2009-04-30

ACELLULAR IMMUNOGENIC COMPOSITIONS AND ACELLULAR VACCINE COMPOSITIONS AGAINST BACILLUS ANTHRACIS

 #128
20090022736
2009-01-22

Monoclonal antibodies that specifically bind to and neutralize toxin, compositions, and methods of use

 #129
20090010928
2009-01-08

Antibodies that bind exotoxin, formulations thereof, and methods of use

 #130
20080311108
2008-12-18

polypeptides

 #131
20080262204
2008-10-23

Recombinant antibodies for the detection and neutralization of anthrax toxin

 #132
20080115244
2008-05-15

Method for producing immunoglobulins containing protection proteins and their use

 #133
20080081042
2008-04-03

Immunization and treatment methods for anthrax

 #134
20080063647
2008-03-13

Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax

 #135
20080020410
2008-01-24

Assays for detection of

#136
20080014202
2008-01-17

Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria

 #137
20070259387
2007-11-08

Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof

 #138
20070231840
2007-10-04

Spore specific antigen

 #139
20070172500
2007-07-26

Anthrax antitoxins

 #140
20070118934
2007-05-24

Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax

 #141
20070116719
2007-05-24

Vaccine delivery

 #142
20070020281
2007-01-25

Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof

 #143
20060286612
2006-12-21

Spore specific antibodies

 #144
20060265787
2006-11-23

Recombinant carrier molecule for expression, delivery and purification of target polypeptides

 #145
20060258842
2006-11-16

Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof

 #146
20060246079
2006-11-02

Neutralizing human antibodies to anthrax toxin

 #147
20060153839
2006-07-13

Production of bispecific molecules using polyethylene glycol linkers

 #148
20060140931
2006-06-29

Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment

 #149
20060121045
2006-06-08

Antibody fragments for protection from pathogen infection and methods of use thereof

 #150
20060099228
2006-05-11

Acellular immunogenic compositions and acellular vaccine compositions against

#151
20050287149
2005-12-29

Human monoclonal antibodies against protective antigen

 #152
20050281830
2005-12-22

Detection, prevention, and treatment systems for anthrax

 #153
20050202026
2005-09-15

Method for producing immunoglobulins containing protection proteins and their use

 #154
20050031633
2005-02-10

Glucan binding protein and glucosyltransferase immunogens

 #155
20050031625
2005-02-10

Methods and compositions for conversion of antibody activity

 #156
20050026271
2005-02-03

Glucosyltransferase immunogens